GO:1900135 positive regulation of renin secretion into blood stream: Signaling Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1900135 describes any process that activates or increases the frequency, rate or extent of renin secretion into the bloodstream.
Renin release is a critical step in the renin-angiotensin system (RAS), controlling blood pressure and fluid balance.
Beta-adrenergic stimulation and sympathetic nerve activity are major positive regulators of renin secretion, acting through cAMP in some tissues.
The term is distinct from general renin secretion; it specifically covers positive regulatory inputs such as neural and hormonal signals.
Dysregulation of renin secretion is linked to hypertension and cardiovascular remodeling, as shown in animal models.
Studying this process requires integrated physiological, molecular, and genetic approaches, including CRISPR-based models.

Description

The Gene Ontology (GO) term GO:1900135, positive regulation of renin secretion into blood stream, defines the biological processes that activate or increase the release of renin into the circulation. Renin is an aspartyl protease secreted by juxtaglomerular cells of the kidney and is the rate-limiting enzyme of the renin-angiotensin system (RAS), which regulates blood pressure, electrolyte balance, and vascular tone. Understanding how renin secretion is positively regulated is essential for deciphering hypertension, heart failure, and related cardiovascular disorders. This article integrates the QuickGO definition with published evidence to provide a research-grade overview of the term, its mechanisms, key genes, and experimental models.

positive regulation of renin secretion into blood stream At A Glance

GO ID GO:1900135
GO term positive regulation of renin secretion into blood stream
Ontology biological_process
Synonym activation of renin release into blood stream; upregulation of renin secretion into blood stream; positive regulation of renin release into blood stream
Major function Increases the release of renin from juxtaglomerular cells into the circulation, thereby activating the renin-angiotensin system
Related process Renin secretion, renin-angiotensin system, blood pressure regulation
Key regulators Beta-adrenergic receptors, sympathetic nervous system, cAMP signaling
Disease relevance Hypertension, cardiac hypertrophy, cardiovascular remodeling

What Is GO:1900135?

GO:1900135 is a biological process term that encompasses any molecular event or pathway that activates or increases the frequency, rate, or extent of renin secretion into the bloodstream. It includes signals that stimulate renin release, such as beta-adrenergic receptor activation and sympathetic nerve stimulation, which can elevate intracellular cAMP and promote exocytosis of renin-containing granules. This term is a child of positive regulation of renin secretion and is specifically restricted to secretion into the blood stream, distinguishing it from local tissue renin effects.

Why Is positive regulation of renin secretion into blood stream Important in Cell Biology?

Positive regulation of renin secretion into the blood stream is a central control point for blood pressure and fluid homeostasis. Dysregulation of this process can lead to hypertension, heart failure, and renal disease. Understanding the molecular mechanisms that stimulate renin release provides targets for antihypertensive therapies and insights into cardiovascular pathophysiology.
Controls systemic blood pressure via the renin-angiotensin system.
Integrates neural and hormonal signals to modulate renin release.
Beta-adrenergic stimulation increases renin secretion through cAMP in certain tissues.
Implicated in left ventricular hypertrophy in spontaneously hypertensive rats.
Provides a therapeutic target for hypertension and heart failure.
Helps explain inter-organ communication between the sympathetic nervous system and kidney.
Relevant to ocular renin-angiotensin system regulation.
Key for understanding fluid-electrolyte balance.
Serves as a model for studying regulated exocytosis.
Links to cardiovascular remodeling and end-organ damage.

What Happens During positive regulation of renin secretion into blood stream?

Initiation by Sympathetic and Beta-Adrenergic Signals
In simple terms: Nerve signals and adrenaline-like molecules tell kidney cells to release renin.
Positive regulation of renin secretion often begins with sympathetic nerve stimulation or beta-adrenergic receptor activation on juxtaglomerular cells. These signals elevate intracellular cAMP, which triggers downstream events leading to renin granule exocytosis. This pathway has been demonstrated in retinal pigment epithelium, where systemic beta-adrenergic stimulation influences the intraocular renin-angiotensin system through cAMP.
cAMP-Dependent Signaling Cascade
In simple terms: A molecule called cAMP acts as an internal messenger to amplify the release signal.
Increased cAMP levels activate protein kinase A (PKA) and other effectors that promote the mobilization of renin-containing secretory granules. In the retinal pigment epithelium, beta-adrenergic stimulation leads to cAMP accumulation and modulation of the local RAS, suggesting a conserved mechanism for regulated renin release.
Exocytosis of Renin Granules
In simple terms: The cell packages renin into small bubbles and releases them into the blood.
Following signaling activation, renin stored in secretory granules fuses with the plasma membrane and releases its contents into the bloodstream. This exocytotic process is the final step of positive regulation of renin secretion into blood stream and is tightly controlled by calcium and cAMP-dependent pathways.
Feedback and Integration with Systemic RAS
In simple terms: The released renin starts a chain reaction that affects blood pressure and is monitored by the body.
Once in the blood, renin cleaves angiotensinogen to angiotensin I, ultimately increasing blood pressure and aldosterone secretion. This systemic feedback can further modulate renin release, and in conditions such as cardiac hypertrophy, the RAS is often overactive. The interplay between local and systemic RAS highlights the importance of precise regulation.

Key Genes Involved in GO:1900135 positive regulation of renin secretion into blood stream

The following genes and proteins are involved in the positive regulation of renin secretion into the blood stream, based on published literature.
GeneMajor RoleResearch Relevance
RENEncodes renin, the enzyme secreted into bloodCentral to RAS and blood pressure regulation
ADRB1Beta-1 adrenergic receptor; mediates sympathetic stimulationActivates cAMP and renin release
ADRB2Beta-2 adrenergic receptor; mediates catecholamine effectsModulates renin secretion in various tissues
GNASG protein alpha subunit; couples beta-adrenergic receptors to adenylyl cyclaseEssential for cAMP production
ADCYAP1Pituitary adenylate cyclase-activating polypeptidePotential regulator of cAMP and renin release
PRKACACatalytic subunit of PKA; mediates cAMP effectsPhosphorylates targets involved in exocytosis
CREB1Transcription factor activated by cAMPMay regulate expression of renin and related genes
AGTR1Angiotensin II receptor type 1Feedback regulation of renin release
AGTR2Angiotensin II receptor type 2Modulates RAS and renin secretion
ACEAngiotensin-converting enzymeGenerates angiotensin II, influencing renin feedback
AGTAngiotensinogenSubstrate for renin; levels affect RAS activity
NOS1Neuronal nitric oxide synthaseRegulates renin secretion via NO signaling
COX2Cyclooxygenase-2Prostaglandin synthesis affects renin release
PTGS2Prostaglandin-endoperoxide synthase 2Involved in macula densa signaling
KCNJ1ROMK potassium channelAffects tubular salt sensing and renin release
WNK1With-no-lysine kinase 1Regulates ion transport and renin secretion
WNK4With-no-lysine kinase 4Modulates distal tubule function and renin

How Is positive regulation of renin secretion into blood stream Regulated?

The positive regulation of renin secretion into the blood stream is controlled by multiple signaling pathways. Beta-adrenergic stimulation and sympathetic nerve activity increase intracellular cAMP, which in turn activates PKA and promotes renin granule exocytosis. This process can be modulated by local factors such as nitric oxide and prostaglandins. In pathological states like cardiac hypertrophy, the RAS is often overactive, suggesting that renin secretion is subject to feedback regulation by angiotensin II and other systemic factors.

positive regulation of renin secretion into blood stream and Human Disease

GeneDisease / BiologyPotential Experimental Model
RENHypertension, renal tubular dysgenesisRen knockout mouse, knock-in of human variants
ADRB1Hypertension, heart failureBeta-1 adrenergic receptor knockout mouse
AGTR1Hypertension, cardiac hypertrophyAgtr1 knockout or transgenic overexpression
ACEHypertension, cardiovascular remodelingAce knockout mouse, pharmacological inhibition
WNK1Pseudohypoaldosteronism type II, hypertensionWnk1 knock-in mouse models
Hypertension and Cardiovascular Remodeling
Excessive positive regulation of renin secretion leads to elevated angiotensin II, which promotes vasoconstriction, sodium retention, and cardiac hypertrophy. In spontaneously hypertensive rats, treatment with Banxia Baizhu Tianma decoction reduced left ventricular hypertrophy, potentially by modulating the RAS. This highlights the clinical relevance of targeting renin secretion in hypertension.
Ocular Renin-Angiotensin System
The intraocular RAS is influenced by systemic beta-adrenergic stimulation through cAMP in the retinal pigment epithelium. Dysregulation of this local system may contribute to ocular diseases such as diabetic retinopathy and glaucoma, although direct evidence for renin secretion into the bloodstream in this context is limited.
Heart Failure and Renal Disease
Chronic activation of renin secretion can worsen heart failure and kidney injury due to sustained angiotensin II effects. Therapies that inhibit the RAS, such as ACE inhibitors and angiotensin receptor blockers, indirectly reduce the consequences of positive renin regulation.

From positive regulation of renin secretion into blood stream-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate renin secretion?CRISPR knockout of gene X in juxtaglomerular cells or whole animal
Does a specific point mutation in gene Y affect renin release?CRISPR point mutation knock-in in cell lines or mice
How does a tag affect renin trafficking?Knock-in of fluorescent or epitope tag on REN
What is the effect of gene Z overexpression on renin secretion?CRISPR activation or transgenic overexpression
Which genes are essential for beta-adrenergic stimulated renin release?CRISPR library screening in renin-secreting cell models
Can we rescue renin secretion in a knockout background?Knock-in of wild-type or mutant cDNA

How to Study the positive regulation of renin secretion into blood stream Process

MethodWhat It MeasuresTypical Application
Renin activity assayEnzymatic activity of renin in blood or mediumAssessing secretion in response to stimuli
cAMP ELISAIntracellular cAMP levelsBeta-adrenergic signaling
Western blotProtein expression and phosphorylationPKA targets, renin processing
CRISPR knockoutLoss-of-function of candidate genesIdentifying essential regulators
CRISPR knock-inIntroduction of specific mutations or tagsStudying variant effects on secretion
RNA-seqTranscriptional changesGlobal response to stimuli
TelemetryBlood pressure in conscious animalsIn vivo validation of renin regulation
Measuring Renin Secretion
Renin secretion can be quantified by measuring renin activity or concentration in blood or culture medium using radioimmunoassays or ELISA. In vitro models, such as isolated juxtaglomerular cells or retinal pigment epithelium, allow direct assessment of regulated secretion.
cAMP and Signaling Assays
Intracellular cAMP levels are measured using luminescent or fluorescent biosensors, or by ELISA, to assess beta-adrenergic stimulation. Downstream PKA activity can be monitored by phosphorylation of target proteins.
Genetic Manipulation and CRISPR Screens
CRISPR-Cas9 knockout, point mutation, and knock-in models enable causal testing of candidate genes in renin secretion. Pooled CRISPR screens can identify novel regulators of renin release in high-throughput formats.
In Vivo Physiological Monitoring
Telemetry and blood pressure measurements in animal models, such as spontaneously hypertensive rats, provide systemic readouts of renin regulation. Pharmacological interventions can link molecular changes to physiological outcomes.

How CRISPR Can Be Used to Study GO:1900135 positive regulation of renin secretion into blood stream

Knockout

CRISPR knockout of genes such as ADRB1 or REN can abolish or reduce positive regulation of renin secretion, allowing researchers to test necessity. These models are valuable for dissecting signaling pathways in juxtaglomerular cells.

Point Mutation

Introducing point mutations in genes like WNK1 or AGTR1 can mimic human variants associated with hypertension, enabling studies of their impact on renin secretion. This approach helps link genotype to molecular phenotype.

Knock-in

Knock-in of fluorescent tags on REN allows real-time tracking of renin granule trafficking and exocytosis. Similarly, knock-in of human disease variants into mouse models can recapitulate pathophysiological states.

Overexpression

CRISPR activation or transgenic overexpression of genes like ADRB2 can enhance renin secretion, providing gain-of-function models to study excessive RAS activation. These models are useful for testing inhibitors.

How EDITGENE Supports positive regulation of renin secretion into blood stream Research

Researchers studying positive regulation of renin secretion into blood stream-related genes often need to determine whether a candidate gene is causally involved in renin release, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of renin secretion into blood stream research.

Frequently Asked Questions About positive regulation of renin secretion into blood stream

GO:1900135 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of renin secretion into the blood stream.
Key genes include REN, ADRB1, ADRB2, GNAS, PRKACA, AGTR1, and WNK1, among others.
Beta-adrenergic stimulation increases intracellular cAMP, which promotes renin granule exocytosis into the bloodstream.
Hypertension, cardiac hypertrophy, heart failure, and renal disease are linked to abnormal renin regulation.
Models include knockout mice, CRISPR-edited cell lines, and pharmacological interventions in hypertensive rats.
CRISPR enables knockout, knock-in, and point mutation of candidate genes to test their causal role in renin release.
cAMP acts as a second messenger that activates PKA and other effectors to trigger renin release.
Yes, sympathetic nerve stimulation is a major positive regulator of renin secretion.
Renin activity assays, ELISA, and cAMP measurements are commonly used to quantify secretion.
Yes, cell models such as retinal pigment epithelium and juxtaglomerular cells can be used to study regulated renin release.

Conclusion

GO:1900135, positive regulation of renin secretion into blood stream, is a critical biological process that integrates neural and hormonal signals to control systemic blood pressure and fluid balance. Dysregulation of this process contributes to hypertension and cardiovascular remodeling, making it a key area for therapeutic intervention. Advances in CRISPR-based models and bioinformatics will continue to unravel the complex regulatory networks governing renin secretion, offering new opportunities for drug discovery and personalized medicine.

References

  1. 1. Martins JR et al.. 2019. Systemic ß adrenergic stimulation/ sympathetic nerve system stimulation influences intraocular RAS through cAMP in the RPE.. Exp Eye Res 189:107828 PMID: 31589840
  2. 2. Jiang JY et al.. 2010. [Effect of banxia baizhu tianma decoction on the left ventricular hypertrophy of hypertrophied myocardium in spontaneously hypertensive rat].. Zhongguo Zhong Xi Yi Jie He Za Zhi 30(10):1061-6 PMID: 21066891
Contact Us
*
*
*
*
How did you hear about us: